Case Report: Novel CXCR2 compound heterozygous variants in an infant with neutropenia - Top-Institutions - MDSpire

Case Report: Novel CXCR2 compound heterozygous variants in an infant with neutropenia

By
Hua Liu
Yinzhu Zhang
Xiao Liu
Jiayue Qin
Chunyi Zhang
Junjin Huang
Danyang Zhang
Hebing Zhou
Ming Yang
Yan Yue
May 29, 2026
0 min

Frontiers In Immunology

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

#1

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Boston, Massachusetts
Key Differentiators
- Hematology
- Oncology
#2

University of Washington School of Medicine and Seattle Children’s

Seattle, Washington
Key Differentiators
- Hematology
#3

Massachusetts General Hospital

Boston, Massachusetts
Key Differentiators
- Hematology
- Endocrinology
#4

National Institutes of Health Clinical Center

Bethesda, Maryland
Key Differentiators
- Hematology
#5

Helsinki University Hospital

Helsinki, Finland
Key Differentiators
- Hematology

Original Source(s)

Frontiers In Immunology

Case Report: Novel CXCR2 compound heterozygous variants in an infant with neutropenia

by Hua Liu, Yinzhu Zhang, Xiao Liu, Jiayue Qin, Chunyi Zhang, Junjin Huang, Danyang Zhang, Hebing Zhou, Ming Yang, Yan Yue
May 29, 2026

Related Content

Frontiers In Medicine

Prognostic significance of coagulation factor activity in acute stroke: a retrospective cohort study

by Yunyan Ye, Yisha Wang, Huan Wang, Lei Zhou, Shengyi Shi, Xuguang Chen
May 29, 2026

Frontiers In Cardiovascular Medicine

The predictive value of platelet-to-high density lipoprotein cholesterol ratio and white blood cell-to-mean platelet volume ratio for coronary artery disease risk in STEMI patients

by Yongxue Xie, Li Mao, Fangling Luo, Jianbin Pi, Qingjun He
May 29, 2026

Blood Cancer Journal

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry